These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28375033)

  • 1. The Role of IFN-alpha in Experimental and Clinical Uveitis.
    Liu X; Diedrichs-Möhring M; Wildner G
    Ocul Immunol Inflamm; 2019; 27(1):23-33. PubMed ID: 28375033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α therapy in noninfectious uveitis.
    Deuter C; Stübiger N; Zierhut M
    Dev Ophthalmol; 2012; 51():90-7. PubMed ID: 22517207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I; Deuter C; Stubiger N; Zierhut M
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.
    Celiker H; Kazokoglu H; Direskeneli H
    Ocul Immunol Inflamm; 2019; 27(1):15-22. PubMed ID: 28700247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
    Deuter CM; Zierhut M; Möhle A; Vonthein R; Stöbiger N; Kötter I
    Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interferon alpha antibodies and autoantibodies in patients with Behçet's disease uveitis treated with recombinant human interferon alpha-2a.
    Aydinoglu-Candan Ö; Araz-Erşan B; Gul A; Badur S; Tugal-Tutkun I
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):457-65. PubMed ID: 25500983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B; Gendron G; Wechsler B; Terrada C; Cassoux N; Huong du LT; Lemaitre C; Fradeau C; LeHoang P; Piette JC
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I; Eckstein AK; Stübiger N; Zierhut M
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behçet's disease: uveitis-therapy with interferon alpha2a - prospective clinical study in 33 patients].
    Stübiger N; Kötter I; Deuter C; Zierhut M
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):768-73. PubMed ID: 11805868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha: a key factor in autoimmune disease?
    Plskova J; Greiner K; Muckersie E; Duncan L; Forrester JV
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease.
    Guillaume-Czitrom S; Berger C; Pajot C; Bodaghi B; Wechsler B; Kone-Paut I
    Rheumatology (Oxford); 2007 Oct; 46(10):1570-3. PubMed ID: 17702770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
    Diedrichs-Möhring M; Kaufmann U; Wildner G
    Prog Retin Eye Res; 2018 Jul; 65():107-126. PubMed ID: 29496590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
    Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new small molecule for treating inflammation and chorioretinal neovascularization in relapsing-remitting and chronic experimental autoimmune uveitis.
    Diedrichs-Möhring M; Leban J; Strobl S; Obermayr F; Wildner G
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(2):1147-57. PubMed ID: 25515581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of interferon alfa-2r in the treatment of autoimmune uveitis (primary or associated with Behçet's disease)].
    Sánchez Román J; Pulido Aguilera MC; Castillo Palma MJ; Ocaña Medina C; Toral Peña A; López-Checa F; Wichmann I
    Rev Clin Esp; 1996 May; 196(5):293-8. PubMed ID: 8768028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High IFN-alpha expression is associated with the induction of experimental autoimmune uveitis (EAU) in Fischer 344 rat.
    Hu YJ; Zang L; Wu YD; Sun B
    Cell Res; 2001 Dec; 11(4):293-300. PubMed ID: 11794322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erosive arthritis and posterior uveitis in Behçet's disease: treatment with interferon alpha and interferon gamma.
    Kötter I; Dürk H; Eckstein A; Zierhut M; Fierlbeck G; Saal JG
    Clin Exp Rheumatol; 1996; 14(3):313-5. PubMed ID: 8809448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.